Blake Dark

The medicines & conditions can be a bit tricky to say😁… but the simple fact is that the NHS is securing innovative treatments for frontline staff to offer first class care to people across the country. I was delighted to share a few stories at the NHS Board meeting last week

My review of UK commercial clinical trials is published today: gov.uk/government/pub…. I'm incredibly grateful to the doctors, nurses, researchers, companies, public servants, charities and patients who contributed.

I'm delighted that pembrolizumab with chemotherapy will be available to women with triple negative breast cancer following another NHS deal. This will benefit up to 1,600 patients each year – like NHS nurse, Lauren who is now almost five years cancer free. bbc.co.uk/news/health-63…

@tomjgreatrex @sportingintel @uglygame @peterrutzler @TheAthletic I’m also interested in the name of the 3rd party that conducted the due-diligence and their ongoing role with FFC.

Grim reading for anybody who cares about reputation of #ffc this morning from @sportingintel and @uglygame. Sad thing is this wasn’t only predictable, it was predicted. See @peterrutzler @TheAthletic piece from a couple of weeks ago. Must do better dailymail.co.uk/sport/sportsne…

@MotherhoodvsCF Thank you Carlie - it is truly something I am proud to have been a part of. Take care .

@pmrleahy @NHSEngland @WhichUK It was a pleasure to have you as part of the team. What a difference you made! I am delighted that you look back upon what you/the team achieved and are rightly proud! Best wishes and stay in touch.

After 3 and a bit enjoyable years at @NHSEngland, tomorrow I start my new job at @WhichUK leading their external affairs 😍 It was a pleasure to work with so many dedicated and smart people at NHSE and make a small contribution to the pandemic and many other important issues /1

Today, @NHSEngland in partnership with @NICEComms, launch the Innovative Medicines Fund - the Fund will continue NHS momentum as an adopter of medical innovation through agreements that also safeguard value for taxpayers. bbc.in/3mn3ltK

Hundreds of people with the most common form of an aggressive lung cancer could survive twice as long, thanks to a drug now available on the NHS. The drug, durvalumab, can double the overall time someone can survive from two and a half to five years. 👉 england.nhs.uk/2022/05/hundre…

With partners @NICEComms and @DHSCgovuk we’ve taken a big step with our #AMR pilot where the UK is really ‘punching above its weight’ to provide a model for health systems Worldwide. bbc.in/3KAWPKk

A revolutionary tumour-stopping drug for lung cancer will be made available to anyone who is eligible, thanks to a new deal announced today. Read how hundreds more patients will now be able to receive this first-of-its-kind treatment. ➡️ england.nhs.uk/2022/03/hundre…

I am pleased that dostarlimab will be available from today via the Cancer Drugs Fund. This is another example of where the CDF will fast-track the most clinically promising treatments to patients whilst further data is collected, which is great news for patients and clinicians

Great news for NHS patients - thanks to the @NHSEngland, @_RocheUK, @NICEComms and @MHRAgovuk working together, the promising lung cancer drug, atezolizumab can be fast-tracked to people with #NSCLC following its licensing through #ProjectOrbis

An important call to arms on AMR. Read more about what NHS England and partners are doing to show leadership in this area bit.ly/3Ij6BiE #TogetherForAntibiotics

@PKUFamily Thank you @PKUFamily we wish you a very merry Christmas too. Take care

Happy Christmas @blakeydark we will raise a glass to you and your colleagues. 🥂🙌

We need access to sapropterin/Kuvan for all ages. Get a deal for generics @blakeydark so this is finally resolved. If the NHS and @NICEComms leave generics on the shelf the system will look ridiculous. @ChrisMRiches

Delighted to announce @NHSEngland has agreed a deal with @Teva_UK to secure a generic version of the drug sapropterin for #PKU patients of all ages in England. After an active 12 months, this latest deal paves the way for 100s of people to benefit from treatment in the New Year

Our NHS commercial medicines deals put innovative treatments into the hands of amazing front-line staff like Dr Elizabeth Wraige. It’s great to hear how this third NHS agreement for new SMA drugs in less than three years is enabling such leaps in patient care & treatment

Excellent news that patients with sickle cell disease will be able to access the first new drug in over 20 years, crizanlizumab. More from @AmandaPritchard here:

Fantastic achievement from the Commercial Medicines Unit who have won the 'Procurement Team of the Year Award’ at the @GOAwardsNews. This award reflects the hard work undertaken to ensure patients with Haemophilia A can access treatments whilst safeguarding the NHS budget

The NHS has today begun the world's largest trial of a new blood test that detects more than 50 types of cancer before symptoms appear. By finding cancer early, we have the best chance of treating it and giving people the best possible chance of survival.

This is one of the most exciting breakthroughs in lung cancer in 20 years. Sotorasib is a precision treatment – now approved in England, but it's a milestone 40 years in the making, with research by @CR_UK and many others. news.cancerresearchuk.org/2021/09/10/nhs…